in Systemic sclerosis
INFLAMMATION & FIBROSIS can be devastating
Think Totality in
Systemic sclerosis (SSc), also called scleroderma, is a complex autoimmune disease driven by pervasive inflammation and fibrosis, yet no single treatment addresses both of these key drivers of disease.1-3
Not an actual patient.
Systemic sclerosis is a rare, debilitating, difficult-to-treat disease driven by inflammation and fibrosis.1,4,5
The paradigm in systemic sclerosis is shifting with emerging methods for disease evaluation.11
It's time for treatments to address the complex interplay between inflammation and fibrosis that drives systemic sclerosis.